68305-78-2 Usage
Uses
Used in Chemical Synthesis:
2-([(4-Bromophenyl)sulfonyl]amino)-4-methylpentanoic acid is used as a chemical intermediate for the synthesis of various organic compounds. Its bromine atom allows for electrophilic aromatic substitution, making it a valuable building block in the creation of new molecules with potential applications in pharmaceuticals, agrochemicals, or other industries.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-([(4-Bromophenyl)sulfonyl]amino)-4-methylpentanoic acid is used as a precursor in the development of new drugs. Its unique structure and reactivity can be exploited to create novel therapeutic agents, potentially leading to the discovery of new treatments for various diseases.
Used in Research and Development:
2-([(4-Bromophenyl)sulfonyl]amino)-4-methylpentanoic acid is used as a research compound in academic and industrial laboratories. Its properties and reactivity are studied to gain insights into the behavior of benzenesulfonamide derivatives, which can contribute to the advancement of organic chemistry and the development of new synthetic methods.
Check Digit Verification of cas no
The CAS Registry Mumber 68305-78-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,3,0 and 5 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 68305-78:
(7*6)+(6*8)+(5*3)+(4*0)+(3*5)+(2*7)+(1*8)=142
142 % 10 = 2
So 68305-78-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H16BrNO4S/c1-8(2)7-11(12(15)16)14-19(17,18)10-5-3-9(13)4-6-10/h3-6,8,11,14H,7H2,1-2H3,(H,15,16)/p-1/t11-/m1/s1
68305-78-2Relevant academic research and scientific papers
PROLINAMIADE DERIVATIVES AS THROMBIN INHIBITOR, PREPRARATION METHOD AND APPLICATION THEREOF
-
Page/Page column, (2013/11/19)
Provided are a compound of formula (I), pharmaceutically acceptable salts thereof, preparation methods and applications thereof for inhibiting thrombin, and applications in the treatment and prevention of thrombin-mediated and thrombin-related diseases.
